Recent Finacing
Recent Raise
Develops single‑pill combinations of NSAIDs and famotidine to reduce NSAID-related gastrointestinal injury, advancing HZT‑501 and HZT‑602 through late‑stage clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
